Affiliation:
1. Department of Neurology, Wayne State University School of Medicine, 3825 Brush Street, Detroit, Michigan 48201
Abstract
Fifty-four patients with acute cerebral infarction were included in a double-blind study to evaluate Decadron® as therapy. When comparison of patients with similar levels of consciousness was made, there was no significant difference between those patients receiving Decadron® and those receiving placebo therapy.
Three patients developed gastrointestinal tract bleeding in the placebo group, but there were none in the Decadron®-treated group.
There was no good correlation between the clinical state of the patient and the CSF pressure, either on admission or during the 14-day course of the study.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)
Cited by
118 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献